Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -50.00% and -0.54%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -50.00% and -0.54%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Aurora Cannabis (ACB) delivered earnings and revenue surprises of +200.00% and +17.21%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Perrigo (PRGO) delivered earnings and revenue surprises of +7.14% and -0.19%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Haemonetics (HAE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of +300.00% and +4.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist.
Cresco Labs Inc. (CRLBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).